How I treat ALK-positive non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How I treat ALK-positive non-small cell lung cancer

Published:2019 Issue: Volume:4 Page:e000524
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

McCusker Michael G.,Russo Alessandro,Scilla Katherine A.,Mehra Ranee,Rolfo Christian^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors;Chia;Clin Epidemiol,2014

2. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

3. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC;Rolfo;J Thorac Oncol,2018

4. Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance;Russo;Expert Rev Anticancer Ther,2016

5. Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology platform Lungscape project;Letovanec;J Thorac Oncol,2018

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer;Frontiers in Pharmacology;2024-07-29

2. Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma;The Oncologist;2024-07-03

3. From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC);Diagnostics;2023-12-25

4. Identification of a novel RSRC1-ALK (R6: A20) fusion using next-generation sequencing technique;Cancer Genetics;2023-11

5. Issues with the targeted therapy of non‑small cell lung cancer with thyroid metastases: A case report;Medicine International;2023-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3